Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) Innovative Solutions Opening (ISO)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Advanced Research Projects Agency for Health (ARPA-H) has issued an Innovative Solutions Opening (ISO) for the Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) program. This initiative seeks to develop a Control Point Validation Engine to improve intensive care unit (ICU) health outcomes by assessing, predicting, and treating immuno-inflammatory dysregulation, with a goal of reducing average ICU stay by 25%. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements.
Scope of Work
The CIRCLE program is a 5-year, 3-phase effort structured around three Technical Areas (TAs) and three Acceleration Platforms (APs):
- TA1: Measure - Develop real-time, tissue-specific immuno-inflammation biomarker sensors and diagnostics.
- TA2: Model - Create personalized computational models (digital twins) to predict critical illness trajectories and identify control points.
- TA3: Modulate - Develop and test interventions to modulate the immune response to control critical illness.
- Acceleration Platforms - Provide independent verification, validation, data analysis, FDA-compliant modeling platforms, and clinical trial support.
Contract Details
- Type: Other Transaction (OT) Agreements
- Duration: 5-year, 3-phase program
- Set-Aside: None specified. Eligibility is broad, including universities, non-profit organizations, small businesses, and other than small businesses. Federally Funded Research and Development Centers (FFRDCs) and U.S. Government entities are excluded. Non-U.S. entities may participate.
- Product Service Code: AN13 (Health R&D Services; Health Care Services; Experimental Development)
Submission & Evaluation
Proposers must submit a solution summary prior to a full proposal. Proposals will be evaluated on Overall Scientific and Technical Merit, Proposer's Capabilities and/or Related Experience, Price/Value Analysis, and Relevance to the ARPA-H Mission. A commercialization strategy narrative is required for Type A proposals.
Key Dates
- Proposers' Day: March 11, 2026
- Solution Summaries Due: March 30, 2026, 1 PM ET
- Questions Due: May 22, 2026, 1 PM ET
- Full Proposals Due: May 28, 2026, 1 PM ET
Important Notes
Several amendments have been issued. Amendment 1 updated the proposal submission date to May 28, 2026. Amendment 4 corrected the "Total Amount Sheet" in the Attachment D, Volume 2 (Price Cost Proposal Workbook), adding Fee and Profit. Proposers must use the latest version of the cost workbook and adhere to all instructions in the provided templates for technical, management, administrative, and task description volumes.